01 1AX Pharmaceutical Corp
02 1Aino Co., Ltd.of North China Pharmaceutical Group
03 3Chemo Biosynthesis s.r.l.
04 2DARMERICA, LLC
05 1Fagron Inc
06 1HEBEI VEYONG PHARMACEUTICAL CO., LTD
07 2Hovione PharmaScience Limited
08 1Kalchem International inc
09 1LETCO MEDICAL, LLC
10 1Medisca Inc
11 1Professional Compounding Centers of America
12 1Qingdao Biopeptek Co., Ltd.
13 1Shandong Qilu King-Phar Pharmaceutical Co., Ltd.
14 1Willow Birch Pharma, Inc
15 1Willow Birch Pharma, Inc.
16 1Zhejiang Hisun Pharmaceutical Co., Ltd.
01 3IVERMECTIN
02 17Ivermectin
01 1Canada
02 4China
03 1Netherlands
04 2Portugal
05 3Spain
06 8U.S.A
07 1United Kingdom
NDC Package Code : 51552-0619
Start Marketing Date : 1998-04-01
End Marketing Date : 2025-08-23
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 49885-0006
Start Marketing Date : 2019-09-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 55018-121
Start Marketing Date : 1998-07-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 55018-221
Start Marketing Date : 2009-03-19
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 60592-316
Start Marketing Date : 2019-12-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-2468
Start Marketing Date : 2021-01-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-5152
Start Marketing Date : 2021-09-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 10695-052
Start Marketing Date : 2019-03-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 10695-052
Start Marketing Date : 2019-09-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 58623-0047
Start Marketing Date : 2014-10-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Ivermectin B1a manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ivermectin B1a, including repackagers and relabelers. The FDA regulates Ivermectin B1a manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ivermectin B1a API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ivermectin B1a manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ivermectin B1a supplier is an individual or a company that provides Ivermectin B1a active pharmaceutical ingredient (API) or Ivermectin B1a finished formulations upon request. The Ivermectin B1a suppliers may include Ivermectin B1a API manufacturers, exporters, distributors and traders.
click here to find a list of Ivermectin B1a suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ivermectin B1a as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ivermectin B1a API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ivermectin B1a as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ivermectin B1a and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ivermectin B1a NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ivermectin B1a suppliers with NDC on PharmaCompass.
We have 15 companies offering Ivermectin B1a
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
